Zhi Dan Jia

Chairman at Sinopharm YiXin Pharmaceutical Co., Ltd.

63 year

Health Technology

Profile

Zhi Dan Jia is currently the Chairman at Sinopharm YiXin Pharmaceutical Co., Ltd.
Prior to this, he worked as the General Manager & Director at Shanghai Shyndec Pharmaceutical Co., Ltd.

Zhi Dan Jia active positions

Companies	Position	Start
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Chairman	-

All active positions of Zhi Dan Jia

Former positions of Zhi Dan Jia

Companies	Position	End
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Chief Executive Officer	-

See the detail of Zhi Dan Jia's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zhi Dan Jia's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Health Technology

Private companies	1
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Health Technology